Safety Study of CD-NP in Heart Failure

Status:
Completed

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

An open-label study designed to determine the safety, tolerability and pharmacodynamics of CD-NP infusions in heart failure patients.

Phase 1

Nile Therapeutics